In cardiovascular disease, pyruvate dehydrogenase kinase (PDK)-dependent inhibition of PDH axis is a major immunometabolic pathway associated with vascular inflammation, targeting this axis could inhibit vascular inflammation and atherogenesis [49]. Here, PDP1 is linked to cardiovascular disorder.